Skip to main content
Top
Published in: Heart Failure Reviews 3/2012

01-05-2012

The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

Authors: Filippos Triposkiadis, Randall C. Starling, Harisios Boudoulas, Gregory Giamouzis, Javed Butler

Published in: Heart Failure Reviews | Issue 3/2012

Login to get access

Abstract

There has been increasing interest on the so-called cardiorenal syndrome (CRS), defined as a complex pathophysiological disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other. In this review, we contend that there is lack of evidence warranting the adoption of a specific clinical construct such as the CRS within the heart failure (HF) syndrome by demonstrating that: (a) the approaches and tools regarding the definition of kidney involvement in HF are suboptimal; (b) development of renal failure in HF is often confounded by age, hypertension, and diabetes; (c) worsening of renal function (WRF) in HF may be largely independent of alterations in cardiac function; (d) the bidirectional association between HF and renal failure is not unique and represents one of the several such associations encountered in HF; and (e) inflammation is a common denominator for HF and associated noncardiac morbidities. Based on these arguments, we believe that dissecting one of the multiple bidirectional associations in HF and constructing the so-called cardiorenal syndrome is not justified pathophysiologically. Fully understanding of all morbid associations and not only the cardiorenal is of great significance for the clinician who is caring for the patient with HF.
Literature
2.
go back to reference Liang KV, Williams AW, Greene EL, Redfield MM (2008) Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36:S75–S88PubMedCrossRef Liang KV, Williams AW, Greene EL, Redfield MM (2008) Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36:S75–S88PubMedCrossRef
3.
go back to reference Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMedCrossRef Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMedCrossRef
4.
go back to reference Heywood JT (2004) The cardiorenal syndrome: lessons from the adhere database and treatment options. Heart Fail Rev 9:195–201PubMedCrossRef Heywood JT (2004) The cardiorenal syndrome: lessons from the adhere database and treatment options. Heart Fail Rev 9:195–201PubMedCrossRef
5.
go back to reference Boerrigter G, Burnett JC Jr (2004) Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications. Curr Heart Fail Rep 1:113–120PubMedCrossRef Boerrigter G, Burnett JC Jr (2004) Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications. Curr Heart Fail Rep 1:113–120PubMedCrossRef
6.
go back to reference Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House A, Katz NM, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P (2010) Cardiorenal syndromes: an executive summary from the consensus conference of the acute dialysis quality initiative (adqi). Contrib Nephrol 165:54–67PubMedCrossRef Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House A, Katz NM, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P (2010) Cardiorenal syndromes: an executive summary from the consensus conference of the acute dialysis quality initiative (adqi). Contrib Nephrol 165:54–67PubMedCrossRef
7.
go back to reference Carubelli V, Metra M, Lombardi C, Bettari L, Bugatti S, Lazzarini V, Dei Cas L (2011) Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. Heart Fail Rev. doi:10.1007/s10741-011-9265-z Carubelli V, Metra M, Lombardi C, Bettari L, Bugatti S, Lazzarini V, Dei Cas L (2011) Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. Heart Fail Rev. doi:10.​1007/​s10741-011-9265-z
9.
go back to reference Schroten NF, Gaillard CA, van Veldhuisen DJ, Szymanski MK, Hillege HL, de Boer RA (2011) New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev. doi:10.1007/s10741-011-9262-2 Schroten NF, Gaillard CA, van Veldhuisen DJ, Szymanski MK, Hillege HL, de Boer RA (2011) New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev. doi:10.​1007/​s10741-011-9262-2
10.
go back to reference Hauptman PJ, Mann DL (2011) The vagus nerve and autonomic imbalance in heart failure: past, present, and future. Heart Fail Rev 16:97–99PubMedCrossRef Hauptman PJ, Mann DL (2011) The vagus nerve and autonomic imbalance in heart failure: past, present, and future. Heart Fail Rev 16:97–99PubMedCrossRef
11.
go back to reference Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J (2009) The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54:1747–1762PubMedCrossRef Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J (2009) The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54:1747–1762PubMedCrossRef
12.
go back to reference Schwartz PJ, De Ferrari GM (2011) Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev 16:101–107PubMedCrossRef Schwartz PJ, De Ferrari GM (2011) Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev 16:101–107PubMedCrossRef
13.
go back to reference Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878PubMedCrossRef Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878PubMedCrossRef
14.
go back to reference Braam B, Cupples WA, Joles JA, Gaillard C (2011) Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev. doi:10.1007/s10741-011-9246-2 Braam B, Cupples WA, Joles JA, Gaillard C (2011) Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev. doi:10.​1007/​s10741-011-9246-2
15.
go back to reference Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the escape trial. J Am Coll Cardiol 51:1268–1274PubMedCrossRef Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the escape trial. J Am Coll Cardiol 51:1268–1274PubMedCrossRef
16.
go back to reference Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596PubMedCrossRef Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596PubMedCrossRef
17.
go back to reference Sinkeler SJ, Damman K, van Veldhuisen DJ, Hillege H, Navis G (2011) A re-appraisal of volume status and renal function impairment in chronic heart failure: Combined effects of pre-renal failure and venous congestion on renal function. Heart Fail Rev. doi:10.1007/s10741-011-9233-7 Sinkeler SJ, Damman K, van Veldhuisen DJ, Hillege H, Navis G (2011) A re-appraisal of volume status and renal function impairment in chronic heart failure: Combined effects of pre-renal failure and venous congestion on renal function. Heart Fail Rev. doi:10.​1007/​s10741-011-9233-7
18.
go back to reference Costanzo MR, Jessup M (2011) Treatment of congestion in heart failure with diuretics and extracorporeal therapies: Effects on symptoms, renal function, and prognosis. Heart Fail Rev. doi:10.1007/s10741-011-9248-0 Costanzo MR, Jessup M (2011) Treatment of congestion in heart failure with diuretics and extracorporeal therapies: Effects on symptoms, renal function, and prognosis. Heart Fail Rev. doi:10.​1007/​s10741-011-9248-0
19.
go back to reference Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T, Heinisch C, Noveanu M, Frischknecht B, Baumann U, Jaeger KA, Mueller C (2011) Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail 13:432–439PubMedCrossRef Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T, Heinisch C, Noveanu M, Frischknecht B, Baumann U, Jaeger KA, Mueller C (2011) Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail 13:432–439PubMedCrossRef
20.
go back to reference Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51:300–306PubMedCrossRef Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51:300–306PubMedCrossRef
21.
go back to reference Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95:1363–1365PubMed Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95:1363–1365PubMed
22.
go back to reference Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC (2010) Rolofylline, an adenosine a1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419–1428PubMedCrossRef Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC (2010) Rolofylline, an adenosine a1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419–1428PubMedCrossRef
23.
go back to reference Metra M, O’Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G (2011) Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the protect study. Eur Heart J 32:1519–1534PubMedCrossRef Metra M, O’Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G (2011) Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the protect study. Eur Heart J 32:1519–1534PubMedCrossRef
24.
go back to reference Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O’Connor CM, Givertz MM (2011) Effects of the adenosine a1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: Results from protect (placebo-controlled randomized study of the selective adenosine a1 receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function). J Am Coll Cardiol 57:1899–1907PubMedCrossRef Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O’Connor CM, Givertz MM (2011) Effects of the adenosine a1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: Results from protect (placebo-controlled randomized study of the selective adenosine a1 receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function). J Am Coll Cardiol 57:1899–1907PubMedCrossRef
25.
go back to reference Fildes JE, Shaw SM, Yonan N, Williams SG (2009) The immune system and chronic heart failure: is the heart in control? J Am Coll Cardiol 53:1013–1020PubMedCrossRef Fildes JE, Shaw SM, Yonan N, Williams SG (2009) The immune system and chronic heart failure: is the heart in control? J Am Coll Cardiol 53:1013–1020PubMedCrossRef
26.
go back to reference Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, Uriel N, Cotter G (2011) Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev. doi:10.1007/s10741-011-9261-3 Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, Uriel N, Cotter G (2011) Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev. doi:10.​1007/​s10741-011-9261-3
27.
go back to reference Li W, Olshansky B (2011) Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail Rev 16:137–145PubMedCrossRef Li W, Olshansky B (2011) Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail Rev 16:137–145PubMedCrossRef
29.
go back to reference Karayannis G, Giamouzis G, Alexandridis E, Kamvrogiannis P, Butler J, Skoularigis J, Triposkiadis F (2011) Prevalence of impaired coronary flow reserve and its association with left ventricular diastolic function in asymptomatic individuals with major cardiovascular risk factors. Eur J Cardiovasc Prev Rehabil 18:326–333PubMedCrossRef Karayannis G, Giamouzis G, Alexandridis E, Kamvrogiannis P, Butler J, Skoularigis J, Triposkiadis F (2011) Prevalence of impaired coronary flow reserve and its association with left ventricular diastolic function in asymptomatic individuals with major cardiovascular risk factors. Eur J Cardiovasc Prev Rehabil 18:326–333PubMedCrossRef
30.
go back to reference Willemsen S, Hartog JW, Heiner-Fokkema MR, van Veldhuisen DJ, Voors AA (2011) Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome. Heart Fail Rev. doi:10.1007/s10741-010-9225-z Willemsen S, Hartog JW, Heiner-Fokkema MR, van Veldhuisen DJ, Voors AA (2011) Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome. Heart Fail Rev. doi:10.​1007/​s10741-010-9225-z
31.
go back to reference Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P (2008) Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52:818–827PubMedCrossRef Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P (2008) Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52:818–827PubMedCrossRef
32.
go back to reference Palazzuoli A, Antonelli G, Nuti R (2011) Anemia in cardio-renal syndrome: clinical impact and pathophysiologic mechanisms. Heart Fail Rev 16:603–607PubMedCrossRef Palazzuoli A, Antonelli G, Nuti R (2011) Anemia in cardio-renal syndrome: clinical impact and pathophysiologic mechanisms. Heart Fail Rev 16:603–607PubMedCrossRef
33.
go back to reference Silverberg DS (2011) The role of erythropoiesis stimulating agents and intravenous (iv) iron in the cardio renal anemia syndrome. Heart Fail Rev 16:609–614PubMedCrossRef Silverberg DS (2011) The role of erythropoiesis stimulating agents and intravenous (iv) iron in the cardio renal anemia syndrome. Heart Fail Rev 16:609–614PubMedCrossRef
34.
go back to reference Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O’Connor CM, She L, Sun JL, Yancy CW, Fonarow GC (2008) Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the optimize-hf registry). Am J Cardiol 101:223–230PubMedCrossRef Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O’Connor CM, She L, Sun JL, Yancy CW, Fonarow GC (2008) Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the optimize-hf registry). Am J Cardiol 101:223–230PubMedCrossRef
36.
go back to reference Felker GM, O’Connor CM, Braunwald E (2009) Loop diuretics in acute decompensated heart failure: necessary? evil? a necessary evil? Circ Heart Fail 2:56–62PubMedCrossRef Felker GM, O’Connor CM, Braunwald E (2009) Loop diuretics in acute decompensated heart failure: necessary? evil? a necessary evil? Circ Heart Fail 2:56–62PubMedCrossRef
37.
go back to reference Schrier RW (2006) Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47:1–8PubMedCrossRef Schrier RW (2006) Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47:1–8PubMedCrossRef
38.
go back to reference Chittineni H, Miyawaki N, Gulipelli S, Fishbane S (2007) Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure. Am J Nephrol 27:55–62PubMedCrossRef Chittineni H, Miyawaki N, Gulipelli S, Fishbane S (2007) Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure. Am J Nephrol 27:55–62PubMedCrossRef
39.
go back to reference Giamouzis G, Butler J, Triposkiadis F (2011) Renal function in advanced heart failure. Congest Heart Fail 17:180–188PubMedCrossRef Giamouzis G, Butler J, Triposkiadis F (2011) Renal function in advanced heart failure. Congest Heart Fail 17:180–188PubMedCrossRef
40.
go back to reference Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith AL, Dunbar S, Triposkiadis F, Butler J (2011) Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail 17:54–75PubMedCrossRef Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith AL, Dunbar S, Triposkiadis F, Butler J (2011) Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail 17:54–75PubMedCrossRef
41.
go back to reference Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (posh). Eur Heart J 27:1216–1222PubMedCrossRef Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (posh). Eur Heart J 27:1216–1222PubMedCrossRef
42.
go back to reference Cruz DN, Gheorghiade M, Palazuolli A, Ronco C, Bagshaw SM (2011) Epidemiology and outcome of the cardio-renal syndrome. Heart Fail Rev 16:531–542PubMedCrossRef Cruz DN, Gheorghiade M, Palazuolli A, Ronco C, Bagshaw SM (2011) Epidemiology and outcome of the cardio-renal syndrome. Heart Fail Rev 16:531–542PubMedCrossRef
43.
go back to reference Klein L, Massie BM, Leimberger JD, O’Connor CM, Pina IL, Adams KF Jr, Califf RM, Gheorghiade M (2008) Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (optime-chf). Circ Heart Fail 1:25–33PubMedCrossRef Klein L, Massie BM, Leimberger JD, O’Connor CM, Pina IL, Adams KF Jr, Califf RM, Gheorghiade M (2008) Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (optime-chf). Circ Heart Fail 1:25–33PubMedCrossRef
44.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (adqi) group. Crit Care 8:R204–R212PubMedCrossRef Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (adqi) group. Crit Care 8:R204–R212PubMedCrossRef
45.
go back to reference Winearls CG, Glassock RJ (2009) Dissecting and refining the staging of chronic kidney disease. Kidney Int 75:1009–1014PubMedCrossRef Winearls CG, Glassock RJ (2009) Dissecting and refining the staging of chronic kidney disease. Kidney Int 75:1009–1014PubMedCrossRef
46.
go back to reference Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160:685–693PubMedCrossRef Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160:685–693PubMedCrossRef
47.
go back to reference Toto RD (1994) Renal insufficiency due to angiotensin-converting enzyme inhibitors. Miner Electrolyte Metab 20:193–200PubMed Toto RD (1994) Renal insufficiency due to angiotensin-converting enzyme inhibitors. Miner Electrolyte Metab 20:193–200PubMed
48.
go back to reference Giamouzis G, Butler J, Starling RC, Karayannis G, Nastas J, Parisis C, Rovithis D, Economou D, Savvatis K, Kirlidis T, Tsaknakis T, Skoularigis J, Westermann D, Tschope C, Triposkiadis F (2010) Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the dopamine in acute decompensated heart failure (dad-hf) trial. J Card Fail 16:922–930PubMedCrossRef Giamouzis G, Butler J, Starling RC, Karayannis G, Nastas J, Parisis C, Rovithis D, Economou D, Savvatis K, Kirlidis T, Tsaknakis T, Skoularigis J, Westermann D, Tschope C, Triposkiadis F (2010) Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the dopamine in acute decompensated heart failure (dad-hf) trial. J Card Fail 16:922–930PubMedCrossRef
49.
go back to reference Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805PubMedCrossRef Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805PubMedCrossRef
50.
go back to reference Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572–580PubMedCrossRef Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572–580PubMedCrossRef
51.
go back to reference Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O’Connor C, Adams KF, Orlandi C, Gheorghiade M (2007) Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the acute and chronic therapeutic impact of a vasopressin antagonist in chronic heart failure (activ in chf) study. J Card Fail 13:360–364PubMedCrossRef Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O’Connor C, Adams KF, Orlandi C, Gheorghiade M (2007) Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the acute and chronic therapeutic impact of a vasopressin antagonist in chronic heart failure (activ in chf) study. J Card Fail 13:360–364PubMedCrossRef
52.
go back to reference Giamouzis G, Kalogeropoulos AP, Georgiopoulou VV, Agha SA, Rashad MA, Laskar SR, Smith AL, Butler J (2009) Incremental value of renal function in risk prediction with the Seattle heart failure model. Am Heart J 157:299–305PubMedCrossRef Giamouzis G, Kalogeropoulos AP, Georgiopoulou VV, Agha SA, Rashad MA, Laskar SR, Smith AL, Butler J (2009) Incremental value of renal function in risk prediction with the Seattle heart failure model. Am Heart J 157:299–305PubMedCrossRef
53.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef
54.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470PubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470PubMed
55.
go back to reference Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A (2005) Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 46:233–241PubMedCrossRef Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A (2005) Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 46:233–241PubMedCrossRef
56.
go back to reference Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd (2009) For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 75:1071–1078PubMedCrossRef Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd (2009) For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 75:1071–1078PubMedCrossRef
57.
go back to reference Poggio ED, Rule AD, Tanchanco R, Arrigain S, Butler RS, Srinivas T, Stephany BR, Meyer KH, Nurko S, Fatica RA, Shoskes DA, Krishnamurthi V, Goldfarb DA, Gill I, Schreiber MJ Jr (2009) Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 75:1079–1087PubMedCrossRef Poggio ED, Rule AD, Tanchanco R, Arrigain S, Butler RS, Srinivas T, Stephany BR, Meyer KH, Nurko S, Fatica RA, Shoskes DA, Krishnamurthi V, Goldfarb DA, Gill I, Schreiber MJ Jr (2009) Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 75:1079–1087PubMedCrossRef
58.
go back to reference Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute. Circulation 119:3070–3077PubMedCrossRef Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute. Circulation 119:3070–3077PubMedCrossRef
59.
go back to reference Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS (2006) Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166:1884–1891PubMedCrossRef Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS (2006) Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166:1884–1891PubMedCrossRef
60.
go back to reference Fehrman-Ekholm I, Skeppholm L (2004) Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 38:73–77PubMedCrossRef Fehrman-Ekholm I, Skeppholm L (2004) Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 38:73–77PubMedCrossRef
61.
go back to reference Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DD, Hubbard RB, Bulpitt CJ, Fletcher AE (2009) Ckd and mortality risk in older people: a community-based population study in the united kingdom. Am J Kidney Dis 53:950–960PubMedCrossRef Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DD, Hubbard RB, Bulpitt CJ, Fletcher AE (2009) Ckd and mortality risk in older people: a community-based population study in the united kingdom. Am J Kidney Dis 53:950–960PubMedCrossRef
62.
go back to reference Hermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, Heine RJ, Stehouwer CD (2007) Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the hoorn study. J Am Soc Nephrol 18:1942–1952PubMedCrossRef Hermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, Heine RJ, Stehouwer CD (2007) Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the hoorn study. J Am Soc Nephrol 18:1942–1952PubMedCrossRef
63.
go back to reference Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O’Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147:331–338PubMedCrossRef Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O’Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147:331–338PubMedCrossRef
64.
go back to reference Cioffi G, Tarantini L, Pulignano G, Del Sindaco D, De Feo S, Opasich C, Dilenarda A, Stefenelli C, Furlanello F (2007) Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure. J Cardiovasc Med (Hagerstown) 8:419–427CrossRef Cioffi G, Tarantini L, Pulignano G, Del Sindaco D, De Feo S, Opasich C, Dilenarda A, Stefenelli C, Furlanello F (2007) Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure. J Cardiovasc Med (Hagerstown) 8:419–427CrossRef
65.
go back to reference Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI (2000) Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 85:1110–1113PubMedCrossRef Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI (2000) Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 85:1110–1113PubMedCrossRef
66.
go back to reference Weinfeld MS, Chertow GM, Stevenson LW (1999) Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138:285–290PubMedCrossRef Weinfeld MS, Chertow GM, Stevenson LW (1999) Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138:285–290PubMedCrossRef
67.
go back to reference Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67PubMedCrossRef Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67PubMedCrossRef
68.
go back to reference Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272PubMedCrossRef Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272PubMedCrossRef
69.
go back to reference Testani JM, McCauley BD, Kimmel SE, Shannon RP (2010) Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. Am J Cardiol 106:1763–1769PubMedCrossRef Testani JM, McCauley BD, Kimmel SE, Shannon RP (2010) Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. Am J Cardiol 106:1763–1769PubMedCrossRef
70.
go back to reference Stevenson LW (2006) Are hemodynamic goals viable in tailoring heart failure therapy? hemodynamic goals are relevant. Circulation. 113:1020–1027 (discussion 1033) Stevenson LW (2006) Are hemodynamic goals viable in tailoring heart failure therapy? hemodynamic goals are relevant. Circulation. 113:1020–1027 (discussion 1033)
71.
go back to reference Damman K, Voors AA (2007) Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application: editorial to: “Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine by yilmaz et al.”. Cardiovasc Drugs Ther 21:403–404 Damman K, Voors AA (2007) Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application: editorial to: “Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine by yilmaz et al.”. Cardiovasc Drugs Ther 21:403–404
72.
go back to reference Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the escape trial. JAMA 294:1625–1633PubMedCrossRef Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the escape trial. JAMA 294:1625–1633PubMedCrossRef
73.
go back to reference Ungar A, Fumagalli S, Marini M, Di Serio C, Tarantini F, Boncinelli L, Baldereschi G, Valoti P, La Cava G, Olianti C, Masotti G, Marchionni N (2004) Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med 32:1125–1129PubMedCrossRef Ungar A, Fumagalli S, Marini M, Di Serio C, Tarantini F, Boncinelli L, Baldereschi G, Valoti P, La Cava G, Olianti C, Masotti G, Marchionni N (2004) Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med 32:1125–1129PubMedCrossRef
74.
go back to reference Elkayam U, Ng TM, Hatamizadeh P, Janmohamed M, Mehra A (2008) Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action. Circulation 117:200–205PubMedCrossRef Elkayam U, Ng TM, Hatamizadeh P, Janmohamed M, Mehra A (2008) Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action. Circulation 117:200–205PubMedCrossRef
75.
go back to reference Shippy CR, Appel PL, Shoemaker WC (1984) Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit Care Med 12:107–112PubMedCrossRef Shippy CR, Appel PL, Shoemaker WC (1984) Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit Care Med 12:107–112PubMedCrossRef
76.
go back to reference Waxman AB (2001) Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure. Clin Chest Med 22:751–758PubMedCrossRef Waxman AB (2001) Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure. Clin Chest Med 22:751–758PubMedCrossRef
77.
go back to reference Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E (2010) The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 12:685–691PubMedCrossRef Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E (2010) The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 12:685–691PubMedCrossRef
78.
go back to reference Sullivan MJ, Higginbotham MB, Cobb FR (1988) Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 77:552–559PubMedCrossRef Sullivan MJ, Higginbotham MB, Cobb FR (1988) Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 77:552–559PubMedCrossRef
79.
go back to reference Agostoni PG, Bussotti M, Palermo P, Guazzi M (2002) Does lung diffusion impairment affect exercise capacity in patients with heart failure? Heart 88:453–459PubMedCrossRef Agostoni PG, Bussotti M, Palermo P, Guazzi M (2002) Does lung diffusion impairment affect exercise capacity in patients with heart failure? Heart 88:453–459PubMedCrossRef
80.
go back to reference Agostoni P, Cattadori G, Bussotti M, Apostolo A (2007) Cardiopulmonary interaction in heart failure. Pulm Pharmacol Ther 20:130–134PubMedCrossRef Agostoni P, Cattadori G, Bussotti M, Apostolo A (2007) Cardiopulmonary interaction in heart failure. Pulm Pharmacol Ther 20:130–134PubMedCrossRef
81.
go back to reference Butler J, Chomsky DB, Wilson JR (1999) Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 34:1802–1806PubMedCrossRef Butler J, Chomsky DB, Wilson JR (1999) Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 34:1802–1806PubMedCrossRef
82.
83.
go back to reference Ahmed MS, Oie E, Vinge LE, von Lueder TG, Attramadal T, Attramadal H (2007) Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling. Cardiovasc Res 74:323–333PubMedCrossRef Ahmed MS, Oie E, Vinge LE, von Lueder TG, Attramadal T, Attramadal H (2007) Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling. Cardiovasc Res 74:323–333PubMedCrossRef
84.
go back to reference Jiang BH, Tardif JC, Sauvageau S, Ducharme A, Shi Y, Martin JG, Dupuis J (2010) Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure. J Card Fail 16:679–688PubMedCrossRef Jiang BH, Tardif JC, Sauvageau S, Ducharme A, Shi Y, Martin JG, Dupuis J (2010) Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure. J Card Fail 16:679–688PubMedCrossRef
85.
go back to reference Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139PubMedCrossRef Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139PubMedCrossRef
86.
go back to reference Lainscak M, Hodoscek LM, Dungen HD, Rauchhaus M, Doehner W, Anker SD, von Haehling S (2009) The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Wien Klin Wochenschr 121:309–313PubMedCrossRef Lainscak M, Hodoscek LM, Dungen HD, Rauchhaus M, Doehner W, Anker SD, von Haehling S (2009) The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Wien Klin Wochenschr 121:309–313PubMedCrossRef
87.
go back to reference Kwon BJ, Kim DB, Jang SW, Yoo KD, Moon KW, Shim BJ, Ahn SH, Cho EJ, Rho TH, Kim JH (2010) Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease. Eur J Heart Fail 12:1339–1344PubMedCrossRef Kwon BJ, Kim DB, Jang SW, Yoo KD, Moon KW, Shim BJ, Ahn SH, Cho EJ, Rho TH, Kim JH (2010) Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease. Eur J Heart Fail 12:1339–1344PubMedCrossRef
88.
go back to reference Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW (2006) Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 8:706–711PubMedCrossRef Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW (2006) Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 8:706–711PubMedCrossRef
89.
go back to reference Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, saskatchewan canada cardiovascular disease in copd patients. Ann Epidemiol 16:63–70PubMedCrossRef Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, saskatchewan canada cardiovascular disease in copd patients. Ann Epidemiol 16:63–70PubMedCrossRef
90.
go back to reference Zvezdin B, Milutinov S, Kojicic M, Hadnadjev M, Hromis S, Markovic M, Gajic O (2009) A postmortem analysis of major causes of early death in patients hospitalized with copd exacerbation. Chest 136:376–380PubMedCrossRef Zvezdin B, Milutinov S, Kojicic M, Hadnadjev M, Hromis S, Markovic M, Gajic O (2009) A postmortem analysis of major causes of early death in patients hospitalized with copd exacerbation. Chest 136:376–380PubMedCrossRef
92.
go back to reference Macnee W, Maclay J, McAllister D (2008) Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:824–833PubMedCrossRef Macnee W, Maclay J, McAllister D (2008) Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:824–833PubMedCrossRef
93.
go back to reference Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, Arzt M (2011) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13:68–75PubMedCrossRef Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, Arzt M (2011) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13:68–75PubMedCrossRef
94.
go back to reference Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, Horstkotte D, Oldenburg O (2011) Cheyne-stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 32:61–74PubMedCrossRef Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, Horstkotte D, Oldenburg O (2011) Cheyne-stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 32:61–74PubMedCrossRef
95.
go back to reference Kasai T, Bradley TD (2011) Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol 57:119–127PubMedCrossRef Kasai T, Bradley TD (2011) Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol 57:119–127PubMedCrossRef
96.
go back to reference Bradley TD, Floras JS (2003) Sleep apnea and heart failure: part i: obstructive sleep apnea. Circulation 107:1671–1678PubMedCrossRef Bradley TD, Floras JS (2003) Sleep apnea and heart failure: part i: obstructive sleep apnea. Circulation 107:1671–1678PubMedCrossRef
97.
go back to reference Chan JY, Li AM, Au CT, Lo AF, Ng SK, Abdullah VJ, Ho C, Yu CM, Fok TF, Wing YK (2009) Cardiac remodelling and dysfunction in children with obstructive sleep apnoea: a community based study. Thorax 64:233–239PubMedCrossRef Chan JY, Li AM, Au CT, Lo AF, Ng SK, Abdullah VJ, Ho C, Yu CM, Fok TF, Wing YK (2009) Cardiac remodelling and dysfunction in children with obstructive sleep apnoea: a community based study. Thorax 64:233–239PubMedCrossRef
98.
go back to reference Chami HA, Devereux RB, Gottdiener JS, Mehra R, Roman MJ, Benjamin EJ, Gottlieb DJ (2008) Left ventricular morphology and systolic function in sleep-disordered breathing: the sleep heart health study. Circulation 117:2599–2607PubMedCrossRef Chami HA, Devereux RB, Gottdiener JS, Mehra R, Roman MJ, Benjamin EJ, Gottlieb DJ (2008) Left ventricular morphology and systolic function in sleep-disordered breathing: the sleep heart health study. Circulation 117:2599–2607PubMedCrossRef
99.
go back to reference Koshino Y, Villarraga HR, Orban M, Bruce CJ, Pressman GS, Leinveber P, Saleh HK, Konecny T, Kara T, Somers VK, Lopez-Jimenez F (2010) Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults: a possible mechanism for abnormal cardiac function in patients with obstructive sleep apnea. Circ Cardiovasc Imaging 3:282–289PubMedCrossRef Koshino Y, Villarraga HR, Orban M, Bruce CJ, Pressman GS, Leinveber P, Saleh HK, Konecny T, Kara T, Somers VK, Lopez-Jimenez F (2010) Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults: a possible mechanism for abnormal cardiac function in patients with obstructive sleep apnea. Circ Cardiovasc Imaging 3:282–289PubMedCrossRef
100.
go back to reference Chan KH, Wilcox I (2010) Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias. Expert Rev Cardiovasc Ther 8:981–994PubMedCrossRef Chan KH, Wilcox I (2010) Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias. Expert Rev Cardiovasc Ther 8:981–994PubMedCrossRef
101.
go back to reference Coumel P (1993) Cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol 4:338–355PubMedCrossRef Coumel P (1993) Cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol 4:338–355PubMedCrossRef
102.
go back to reference Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the candesartan in heart failure: assessment of reduction in mortality and morbidity (charm) program. Eur J Heart Fail 11:170–177PubMedCrossRef Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the candesartan in heart failure: assessment of reduction in mortality and morbidity (charm) program. Eur J Heart Fail 11:170–177PubMedCrossRef
103.
go back to reference Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC (2010) Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 3:59–64PubMedCrossRef Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC (2010) Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 3:59–64PubMedCrossRef
104.
go back to reference Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis.6:947–967, viii-ix Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis.6:947–967, viii-ix
105.
go back to reference Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, Afeltra A, Sanyal AJ (2010) Cirrhotic cardiomyopathy. J Am Coll Cardiol 56:539–549PubMedCrossRef Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, Afeltra A, Sanyal AJ (2010) Cirrhotic cardiomyopathy. J Am Coll Cardiol 56:539–549PubMedCrossRef
107.
go back to reference Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR (1994) Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 331:574–578PubMedCrossRef Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR (1994) Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 331:574–578PubMedCrossRef
108.
go back to reference Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM (2000) Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant 15(Suppl 3):14–18PubMed Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM (2000) Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant 15(Suppl 3):14–18PubMed
109.
go back to reference Anand IS (2008) Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 52:501–511PubMedCrossRef Anand IS (2008) Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 52:501–511PubMedCrossRef
110.
go back to reference From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL (2006) Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119:591–599PubMedCrossRef From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL (2006) Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119:591–599PubMedCrossRef
111.
go back to reference Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure national registry (adhere) database. J Am Coll Cardiol 47:76–84PubMedCrossRef Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure national registry (adhere) database. J Am Coll Cardiol 47:76–84PubMedCrossRef
112.
go back to reference MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (charm) programme. Eur Heart J 29:1377–1385PubMedCrossRef MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (charm) programme. Eur Heart J 29:1377–1385PubMedCrossRef
113.
go back to reference Kamalesh M, Cleophas TJ (2009) Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39, 505 subjects. J Card Fail 15:305–309PubMedCrossRef Kamalesh M, Cleophas TJ (2009) Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39, 505 subjects. J Card Fail 15:305–309PubMedCrossRef
114.
go back to reference AlZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, Petrie JR, Struthers AD, Lang CC (2009) Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 53:747–753PubMedCrossRef AlZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, Petrie JR, Struthers AD, Lang CC (2009) Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 53:747–753PubMedCrossRef
115.
go back to reference Ashrafian H, Frenneaux MP, Opie LH (2007) Metabolic mechanisms in heart failure. Circulation 116:434–448PubMedCrossRef Ashrafian H, Frenneaux MP, Opie LH (2007) Metabolic mechanisms in heart failure. Circulation 116:434–448PubMedCrossRef
116.
go back to reference Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101:2271–2276PubMed Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101:2271–2276PubMed
117.
go back to reference Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294:334–341PubMedCrossRef Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294:334–341PubMedCrossRef
118.
go back to reference Matsushita K, Blecker S, Pazin-Filho A, Bertoni A, Chang PP, Coresh J, Selvin E (2010) The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study. Diabetes 59:2020–2026PubMedCrossRef Matsushita K, Blecker S, Pazin-Filho A, Bertoni A, Chang PP, Coresh J, Selvin E (2010) The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study. Diabetes 59:2020–2026PubMedCrossRef
119.
go back to reference Thrainsdottir IS, Aspelund T, Gudnason V, Malmberg K, Sigurdsson G, Thorgeirsson G, Hardarson T, Ryden L (2007) Increasing glucose levels and BMI predict future heart failure experience from the reykjavik study. Eur J Heart Fail 9:1051–1057PubMedCrossRef Thrainsdottir IS, Aspelund T, Gudnason V, Malmberg K, Sigurdsson G, Thorgeirsson G, Hardarson T, Ryden L (2007) Increasing glucose levels and BMI predict future heart failure experience from the reykjavik study. Eur J Heart Fail 9:1051–1057PubMedCrossRef
120.
go back to reference Triposkiadis F, Giamouzis G, Butler J (2011) The importance of managing diabetes correctly to prevent heart failure. Expert Rev Cardiovasc Ther 9:257–259PubMedCrossRef Triposkiadis F, Giamouzis G, Butler J (2011) The importance of managing diabetes correctly to prevent heart failure. Expert Rev Cardiovasc Ther 9:257–259PubMedCrossRef
121.
go back to reference MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, Aguilar D, Krum H, McMurray JJ (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 29:1224–1240PubMedCrossRef MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, Aguilar D, Krum H, McMurray JJ (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 29:1224–1240PubMedCrossRef
122.
go back to reference Giamouzis G, Triposkiadis F, Butler J (2010) Metformin use in patients with diabetes mellitus and heart failure: friend or foe? J Card Fail 16:207–210PubMedCrossRef Giamouzis G, Triposkiadis F, Butler J (2010) Metformin use in patients with diabetes mellitus and heart failure: friend or foe? J Card Fail 16:207–210PubMedCrossRef
123.
go back to reference Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85:1364–1373PubMed Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85:1364–1373PubMed
124.
go back to reference Minotti JR, Pillay P, Oka R, Wells L, Christoph I, Massie BM (1993) Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 75:373–381PubMed Minotti JR, Pillay P, Oka R, Wells L, Christoph I, Massie BM (1993) Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 75:373–381PubMed
125.
go back to reference Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA (1996) Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 27:140–145PubMedCrossRef Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA (1996) Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 27:140–145PubMedCrossRef
126.
go back to reference Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zamboni M, Tosoni P, Zardini P (2001) Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol 37:2080–2085PubMedCrossRef Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zamboni M, Tosoni P, Zardini P (2001) Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol 37:2080–2085PubMedCrossRef
127.
go back to reference Coats AJ (1996) The “muscle hypothesis” of chronic heart failure. J Mol Cell Cardiol 28:2255–2262PubMedCrossRef Coats AJ (1996) The “muscle hypothesis” of chronic heart failure. J Mol Cell Cardiol 28:2255–2262PubMedCrossRef
128.
go back to reference Duscha BD, Schulze PC, Robbins JL, Forman DE (2008) Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training. Heart Fail Rev 13:21–37PubMedCrossRef Duscha BD, Schulze PC, Robbins JL, Forman DE (2008) Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training. Heart Fail Rev 13:21–37PubMedCrossRef
129.
130.
go back to reference Fatkin D, Otway R, Richmond Z (2010) Genetics of dilated cardiomyopathy. Heart Fail Clin 6:129–140PubMedCrossRef Fatkin D, Otway R, Richmond Z (2010) Genetics of dilated cardiomyopathy. Heart Fail Clin 6:129–140PubMedCrossRef
131.
go back to reference Picano E, Morales MA, del Ry S, Sicari R (2010) Innate inflammation in myocardial perfusion and its implication for heart failure. Ann N Y Acad Sci 1207:107–115PubMedCrossRef Picano E, Morales MA, del Ry S, Sicari R (2010) Innate inflammation in myocardial perfusion and its implication for heart failure. Ann N Y Acad Sci 1207:107–115PubMedCrossRef
132.
go back to reference Turpeinen AK, Vanninen E, Magga J, Tuomainen P, Kuusisto J, Sipola P, Punnonen K, Vuolteenaho O, Peuhkurinen K (2009) Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy. Clin Physiol Funct Imaging 29:414–419PubMedCrossRef Turpeinen AK, Vanninen E, Magga J, Tuomainen P, Kuusisto J, Sipola P, Punnonen K, Vuolteenaho O, Peuhkurinen K (2009) Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy. Clin Physiol Funct Imaging 29:414–419PubMedCrossRef
133.
go back to reference Cottone S, Lorito MC, Riccobene R, Nardi E, Mule G, Buscemi S, Geraci C, Guarneri M, Arsena R, Cerasola G (2008) Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21:175–179PubMed Cottone S, Lorito MC, Riccobene R, Nardi E, Mule G, Buscemi S, Geraci C, Guarneri M, Arsena R, Cerasola G (2008) Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21:175–179PubMed
134.
go back to reference Kelly KJ, Dominguez JH (2010) Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol 32:469–475PubMedCrossRef Kelly KJ, Dominguez JH (2010) Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol 32:469–475PubMedCrossRef
135.
go back to reference McNicholas WT (2009) Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 180:692–700PubMedCrossRef McNicholas WT (2009) Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 180:692–700PubMedCrossRef
136.
go back to reference Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667PubMedCrossRef Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667PubMedCrossRef
137.
go back to reference Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51PubMedCrossRef Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51PubMedCrossRef
138.
go back to reference Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539–548PubMedCrossRef Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539–548PubMedCrossRef
139.
go back to reference Maher JJ, McGuire RF (1990) Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 86:1641–1648PubMedCrossRef Maher JJ, McGuire RF (1990) Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 86:1641–1648PubMedCrossRef
140.
141.
go back to reference Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L (2005) Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 26:2232–2237PubMedCrossRef Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L (2005) Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 26:2232–2237PubMedCrossRef
142.
go back to reference Means RT Jr (2003) Recent developments in the anemia of chronic disease. Curr Hematol Rep 2:116–121PubMed Means RT Jr (2003) Recent developments in the anemia of chronic disease. Curr Hematol Rep 2:116–121PubMed
143.
144.
go back to reference Garcia C, Feve B, Ferre P, Halimi S, Baizri H, Bordier L, Guiu G, Dupuy O, Bauduceau B, Mayaudon H (2010) Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 36:327–338PubMedCrossRef Garcia C, Feve B, Ferre P, Halimi S, Baizri H, Bordier L, Guiu G, Dupuy O, Bauduceau B, Mayaudon H (2010) Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 36:327–338PubMedCrossRef
145.
go back to reference Kolb H, Mandrup-Poulsen T (2010) The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 53:10–20PubMedCrossRef Kolb H, Mandrup-Poulsen T (2010) The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 53:10–20PubMedCrossRef
146.
go back to reference Ehses JA, Ellingsgaard H, Boni-Schnetzler M, Donath MY (2009) Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction. Arch Physiol Biochem 115:240–247PubMedCrossRef Ehses JA, Ellingsgaard H, Boni-Schnetzler M, Donath MY (2009) Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction. Arch Physiol Biochem 115:240–247PubMedCrossRef
147.
go back to reference Reid MB, Li YP (2001) Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand 171:225–232PubMedCrossRef Reid MB, Li YP (2001) Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand 171:225–232PubMedCrossRef
148.
go back to reference Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R (2003) Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42:861–868PubMedCrossRef Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R (2003) Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42:861–868PubMedCrossRef
149.
go back to reference Adams V, Jiang H, Yu J, Mobius-Winkler S, Fiehn E, Linke A, Weigl C, Schuler G, Hambrecht R (1999) Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 33:959–965PubMedCrossRef Adams V, Jiang H, Yu J, Mobius-Winkler S, Fiehn E, Linke A, Weigl C, Schuler G, Hambrecht R (1999) Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 33:959–965PubMedCrossRef
150.
go back to reference Tsutsui H, Ide T, Hayashidani S, Suematsu N, Shiomi T, Wen J, Nakamura K, Ichikawa K, Utsumi H, Takeshita A (2001) Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 104:134–136PubMedCrossRef Tsutsui H, Ide T, Hayashidani S, Suematsu N, Shiomi T, Wen J, Nakamura K, Ichikawa K, Utsumi H, Takeshita A (2001) Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 104:134–136PubMedCrossRef
151.
go back to reference Middlekauff HR (2010) Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3:537–546PubMedCrossRef Middlekauff HR (2010) Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3:537–546PubMedCrossRef
Metadata
Title
The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?
Authors
Filippos Triposkiadis
Randall C. Starling
Harisios Boudoulas
Gregory Giamouzis
Javed Butler
Publication date
01-05-2012
Publisher
Springer US
Published in
Heart Failure Reviews / Issue 3/2012
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-011-9291-x

Other articles of this Issue 3/2012

Heart Failure Reviews 3/2012 Go to the issue